BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best strong buy stocks to invest in according to Wall Street. In a report released on September 17, Christopher Raymond from Raymond James maintained a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and set a price target of $85.00. BioMarin Pharmaceutical Inc. (BMRN): Among Small-Cap Healthcare Stocks Hedge Funds is Buying BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported total revenues of $825 million in fiscal Q2 2025, up 16% year-ov ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best affordable biotech stocks to invest in now. On September 8, BMO Capital analyst Kostas Biliouris reiterated a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), retaining a price target of $115.00. BioMarin Pharmaceutical Inc. (BMRN): Among Small-Cap Healthcare Stocks Hedge Funds is Buying The analyst told investors that one of the key reasons supporting the optimistic rating is the potential expansion of Palynziq into the adolescent ma ...